Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium
Ivan Foeldvari, Vanessa Smith, John D Pauling(Royal National Hospital for Rheumatic Diseases), Jonathan Li(Massachusetts Institute of Technology), Catherine H. Orteu(Royal Free London NHS Foundation Trust), Patrícia Costa-Reis, Clarissa Pilkington, Maurizio Cutolo, Ozgur Kasapcopur, Dieneke Schonenberg-Meinema, Francesco Del Galdo, Laura Ross, Cosimo Bruni, Kathryn S. Torok, Kim Fligelstone, Jörg Henes, Jens Klotsche, Daniel E. Furst, Clara Gimenez-Roca, Suzanne C. Li(Hackensack Meridian Health), Christopher P. Denton, Edoardo Marrani(Meyer Children's Hospital)
Cited by 0
Related Papers
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
|Journal of Clinical Investigation|2019|240
Interferon‐β mediates stromal cell rescue of T cells from apoptosis
|European Journal of Immunology|1999|199
Fabry disease and the skin: data from FOS, the Fabry outcome survey
|British Journal of Dermatology|2007|178
A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse
|Journal of Autoimmunity|2006|115